Research-literacy siteEducational evidence reviews only — not medical advice, not dosing guidance, not a protocol for human or animal use. Medical disclaimer.

PeptideStacks

Responsible Information Policy

PeptideStacks publishes evidence summaries for research literacy. This page explains why that scope is deliberately narrow.

Why we avoid practical-use instructions

Most peptides discussed on this site are unapproved compounds in the UK. They are not licensed medicines. There is no MHRA-approved indication, no agreed-upon dose, and — for many of them — no human safety data of any quality.

In that context, “how to use” content is unsafe at any level of confidence. We do not publish injection technique, vial-to-syringe arithmetic intended for human or animal use, cycle planners, stack builders for use, or personalised dose calculations.

YMYL sensitivity

Peptides sit in the “Your Money or Your Life” (YMYL) content category. Errors in this category can cause real harm — health, financial, or legal. We hold our content to a higher standard accordingly: stronger sourcing requirements, conservative evidence grades, and explicit framing of what is and is not known.

Not medical or veterinary advice

Nothing on PeptideStacks is medical advice, diagnosis, treatment recommendation, or veterinary advice. No physician–patient relationship is created by reading this content. Readers should consult a qualified, registered healthcare professional for any health concern.

Adverse events and emergencies

If you are experiencing a medical emergency, contact your local emergency services. In the UK, that is 999 (or 111 for urgent but non-life-threatening concerns). Suspected adverse reactions to medicines or peptides should be reported to the MHRA via the Yellow Card scheme and discussed with a clinician.

What we will not publish

  • Editorial sourcing or vendor recommendations within research content. Clearly-labelled sponsor and sister-site placement is permitted in dedicated panels, with disclosure — see our conflict-of-interest page. Sponsor placement is deliberately suppressed on POM-adjacent peptide / stack pages.
  • Importation advice.
  • Self-administration or self-injection instructions.
  • Personalised dose calculations for human or animal use.
  • Cycle planners or protocol generators framed for use.
  • Anti-doping evasion advice.
  • Claims of safety for unapproved compounds.
  • Public-facing advertising of UK prescription-only medicines, including in any sponsor or sister-site placement.

What we do publish

  • Evidence reviews — what published studies have found, with their limitations.
  • Mechanism summaries — how a peptide is believed to act, framed appropriately.
  • Regulatory context — the UK position on each compound, in plain English.
  • Safety signals — adverse events reported in literature, contamination risk, immunogenicity.
  • Misinformation flags — common marketing claims that the evidence does not support.
  • Research-literacy tools — to help readers interpret studies rather than to instruct use.

If you are considering using a peptide

Speak to a qualified clinician. Approved medicines exist for many of the indications peptides are marketed for, and prescribing those medicines is a clinician’s job, not ours. If a clinician has not approved a peptide for use in your case, we cannot fill that gap on a website.